These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35641679)
41. Spectrum of autoimmune liver diseases in western India. Amarapurkar DN; Patel ND J Gastroenterol Hepatol; 2007 Dec; 22(12):2112-7. PubMed ID: 17623034 [TBL] [Abstract][Full Text] [Related]
42. Treg Enhancing Therapies to Treat Autoimmune Diseases. Eggenhuizen PJ; Ng BH; Ooi JD Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677 [TBL] [Abstract][Full Text] [Related]
43. UPDATE OF THE BRAZILIAN SOCIETY OF HEPATOLOGY RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF AUTOIMMUNE DISEASES OF THE LIVER. Couto CA; Terrabuio DRB; Cançado ELR; Porta G; Levy C; Silva AEB; Bittencourt PL; ; Carvalho Filho RJ; Chaves DM; Miura IK; Codes L; Faria LC; Evangelista AS; Farias AQ; Gonçalves LL; Harriz M; Lopes EPA; Luz GO; Oliveira PMC; Oliveira EMG; Schiavon JLN; Sevá-Pereira T Arq Gastroenterol; 2019 Aug; 56(2):232-241. PubMed ID: 31460591 [TBL] [Abstract][Full Text] [Related]
44. Single Topic Conference on Autoimmune Liver Disease from the Canadian Association for the Study of the Liver. Montano-Loza AJ; Allegretti JR; Cheung A; Ebadi M; Jones D; Kerkar N; Levy C; Rizvi S; Vierling JM; Alvarez F; Bai W; Gilmour S; Gulamhusein A; Guttman O; Hansen BE; MacParland S; Mason A; Onofrio F; Santamaria P; Stueck A; Swain M; Vincent C; Ricciuto A; Hirschfield G Can Liver J; 2021; 4(4):401-425. PubMed ID: 35989897 [TBL] [Abstract][Full Text] [Related]
45. Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events. Coukos A; Vionnet J; Obeid M; Bouchaab H; Peters S; Latifyan S; Wicky A; Michielin O; Chtioui H; Moradpour D; Fasquelle F; Sempoux C; Fraga M J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36283734 [TBL] [Abstract][Full Text] [Related]
46. Regulatory T cells in autoimmune hepatitis: an updated overview. Longhi MS; Mieli-Vergani G; Vergani D J Autoimmun; 2021 May; 119():102619. PubMed ID: 33652348 [TBL] [Abstract][Full Text] [Related]
47. Clinical significance of changes in the Th17/Treg ratio in autoimmune liver disease. Feng TT; Zou T; Wang X; Zhao WF; Qin AL World J Gastroenterol; 2017 Jun; 23(21):3832-3838. PubMed ID: 28638223 [TBL] [Abstract][Full Text] [Related]
48. The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis. An Haack I; Derkow K; Riehn M; Rentinck MN; Kühl AA; Lehnardt S; Schott E PLoS One; 2015; 10(11):e0143715. PubMed ID: 26599014 [TBL] [Abstract][Full Text] [Related]
49. Intestinal homeostasis in autoimmune liver diseases. Liu Q; He W; Tang R; Ma X Chin Med J (Engl); 2022 Jul; 135(14):1642-1652. PubMed ID: 36193976 [TBL] [Abstract][Full Text] [Related]
50. [Clinical analysis of liver transplantation in end-stage autoimmune liver diseases]. Gu J; Jiang W; Li J; Zhang N; Zhang L; Wang H; Lu W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1401-1405. PubMed ID: 31898573 [TBL] [Abstract][Full Text] [Related]
51. Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model. Zeniya M; Watanabe F; Morizane T; Shibata M; Maeyama S; Kage M; Nakanuma Y; Toda G; J Gastroenterol; 2005 Dec; 40(12):1148-54. PubMed ID: 16378179 [TBL] [Abstract][Full Text] [Related]
52. CAR Treg: A new approach in the treatment of autoimmune diseases. Beheshti SA; Shamsasenjan K; Ahmadi M; Abbasi B Int Immunopharmacol; 2022 Jan; 102():108409. PubMed ID: 34863655 [TBL] [Abstract][Full Text] [Related]
54. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease. Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983 [TBL] [Abstract][Full Text] [Related]
55. De novo and recurrent liver disease. Ip S; Bhanji RA; Ebadi M; Mason AL; Montano-Loza AJ Best Pract Res Clin Gastroenterol; 2020; 46-47():101688. PubMed ID: 33158472 [TBL] [Abstract][Full Text] [Related]
57. Autoimmune liver disease - are there spectra that we do not know? Fallatah HI; Akbar HO Comp Hepatol; 2011 Sep; 10():9. PubMed ID: 21910861 [TBL] [Abstract][Full Text] [Related]
58. Spectrum of Pediatric Autoimmune Liver Disease and Validation of Its Diagnostic Scores in Indian Children. Sood V; Lal BB; Rawat D; Khanna R; Rastogi A; Bihari C; Kumar G; Alam S J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):e65-e72. PubMed ID: 29901555 [TBL] [Abstract][Full Text] [Related]
59. Cirrhosis and autoimmune liver disease: Current understanding. Liberal R; Grant CR World J Hepatol; 2016 Oct; 8(28):1157-1168. PubMed ID: 27729952 [TBL] [Abstract][Full Text] [Related]
60. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases. Dalekos GN; Gatselis NK Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):197-211. PubMed ID: 31165900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]